The Lollipop War Has Begun
MarketFoolery
The Motley Fool
4.7 • 1.7K Ratings
🗓️ 21 March 2019
⏱️ 18 minutes
🧾️ Download transcript
Summary
Biogen falls 30% after halting trials for its Alzheimer’s drug. Healthcare analyst (and Industry Focus host) Shannon Jones discusses potential next moves for the suddenly-embattled pharmaceutical company. CVS starts selling cannabis products in eight states. Plus, a federal judge sides with the maker of Dum Dum lollipops in a battle against Tootsie Roll.
Get $50 off your first job post at www.LinkedIn.com/Fool.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Thanks to LinkedIn for supporting this episode of Market Foolery. |
| 0:02.3 | LinkedIn Jobs makes it easy to get matched with quality candidates who make the most |
| 0:07.2 | sense for your role. Post a job today at LinkedIn.com slash fool and get $50 off your first job post. |
| 0:15.0 | It's Thursday, March 21st. |
| 0:18.0 | Welcome to Market Fuller. |
| 0:19.0 | I'm Chris Hill joining me in studio. |
| 0:21.0 | It's industry focus host Shannon Jones. Thanks for being here. |
| 0:25.6 | I am so excited to be here especially on today Chris Hill. Thank you for having me |
| 0:30.6 | today. We've got a legal battle in the candy industry. We've got |
| 0:36.5 | CVS experimenting with cannabis. Those take a backseat to the story of the day and |
| 0:41.5 | this is why for those who are wondering |
| 0:44.3 | well why is Shannon Jones on because you know she has her own show that she's busy |
| 0:48.2 | hosting every Wednesday hosting the health care show on industry focus and it's because that from time to time |
| 0:55.3 | the news fairy shows up and every once in a while the news fairy shows up with |
| 1:00.5 | news that makes someone in my position go, oh, it's not just that we need to talk |
| 1:05.2 | about this, we need a specific person to talk about this. |
| 1:09.5 | And when I walked over to Shannon's desk this morning, she turned around and looked at me and said, |
| 1:16.5 | I think I know why you're here. You're here because of BioGen. |
| 1:20.6 | That's right. Today's story is all about Biogen. That's right. |
| 1:22.8 | Today's story is all about biogen and what I can I think comfortably say is the biggest |
| 1:28.0 | most anticipated binary event in biotech for 2019. |
| 1:32.4 | We didn't think we would get data from biogen on their Alzheimer's |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The Motley Fool, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The Motley Fool and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.